Kestra Medical Technologies, Ltd.
KMTS
$17.71
-$0.29-1.61%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | -133.59% | 0.51% | 19.84% | 19.84% | |
| Total Depreciation and Amortization | -47.57% | -43.86% | -9.61% | -9.61% | |
| Total Amortization of Deferred Charges | 84.50% | -13.71% | 304.23% | 304.23% | |
| Total Other Non-Cash Items | 1,972.01% | 19.95% | -31.10% | -31.10% | |
| Change in Net Operating Assets | -256.92% | -91.67% | -1,484.54% | -1,484.54% | |
| Cash from Operations | -58.54% | -16.38% | 14.38% | 14.38% | |
| Capital Expenditure | -91.48% | 18.22% | -243.32% | -243.32% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | 573.81% | -- | -- | -- | |
| Cash from Investing | -86.61% | 18.17% | -269.86% | -269.86% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -100.00% | -100.00% | 106.80% | 106.80% | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -1,210.61% | 80.27% | 637.33% | 637.33% | |
| Cash from Financing | 1,654.68% | -101.00% | 115.85% | 115.85% | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 2,766.90% | -154.58% | 663.33% | 663.33% | |